PRBIX | VWALX | PRBIX / VWALX | |
Total Expense Ratio | 0.45 | 0.09 | 500% |
Annual Report Gross Expense Ratio | 0.70 | 0.09 | 778% |
Fund Existence | 30 years | 24 years | - |
Gain YTD | -0.188 | -2.773 | 7% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 50000 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 763M | 15.6B | 5% |
Annual Yield % from dividends | 3.76 | 4.04 | 93% |
Returns for 1 year | 1.35 | -2.96 | -46% |
Returns for 3 years | 5.51 | -1.28 | -430% |
Returns for 5 years | -2.19 | -10.23 | 21% |
Returns for 10 years | 8.00 | -6.01 | -133% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
FRHC | 143.33 | 3.80 | +2.72% |
Freedom Holding Corp | |||
CNTA | 14.07 | 0.33 | +2.40% |
Centessa Pharmaceuticals plc | |||
RMR | 17.53 | 0.30 | +1.74% |
RMR Group (The) | |||
ABLLL | 24.90 | 0.02 | +0.08% |
Abacus Global Management Inc. 9.875% Fixed Rate Senior Notes due 2028 | |||
AUBN | 23.13 | -1.01 | -4.18% |
Auburn National Bancorporation |